Rajiv Jalan MBBS, MD, PhD, FRCPE, FRCP

Dr. Rajiv Jalan, MBBS, MD, Ph.D., FRCPE, FRCPA leading figure in translational research and clinical care of liver disease, recognized by the publication of over 430 original papers. As a professor of Hepatology at University College London, currently leading a laboratory focused on liver failure while continuing to serve patients as a practicing doctor. Jalan's hypothesis and observations led to the recognition of acute-on-chronic liver failure (ACLF) as a distinct clinical syndrome with defined clinical, prognostic, and pathophysiological characteristics, that marks the culmination of advanced chronic liver disease. Jalan the founder of a number of companies focused on delivering solutions to liver failure, including Yaqrit, the clinical-stage biotechnology company progressing a pipeline of devices and drugs to target all stages of liver failure.